Epirium Bio Funding: $85M Raised, Series A (2019)

Epirium Bio funding overview

Epirium Bio is based in San Francisco. Epirium Bio has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2019. The round record for Epirium Bio runs through 2019; nothing later has been disclosed. Investors on record include Longitude Capital, ARCH Venture Partners, Bluebird Ventures, Adams Street Partners, Vertex Ventures HC, The Longevity Fund. 6 distinct backers are named across the disclosed rounds.

Epirium Bio at a glance

Total raised: $85M
Latest round: Series A
Latest round date: December 2019
Headquarters: San Francisco
Notable investors: Longitude Capital, ARCH Venture Partners, Bluebird Ventures, Adams Street Partners, Vertex Ventures HC, The Longevity Fund

Frequently asked about Epirium Bio funding

How much has Epirium Bio raised?: Epirium Bio has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Epirium Bio?: Longitude Capital, ARCH Venture Partners, Bluebird Ventures, Adams Street Partners, Vertex Ventures HC, The Longevity Fund are named among the investors backing Epirium Bio.
What was the latest Epirium Bio funding round?: The most recent disclosed round is a Series A, announced in December 2019.
Where is Epirium Bio based?: Epirium Bio is based in San Francisco.
When did Epirium Bio last raise?: The last disclosed Epirium Bio round closed in December 2019 at Series A.

Every Epirium Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.

Epirium Bio Funding: $85M Raised, Series A (2019)

Epirium Bio funding overview

Epirium Bio at a glance

Frequently asked about Epirium Bio funding

Companies related to Epirium Bio (35)

Browse related funding lists (8)